VRM
XYL icon

Vectors Research Management’s Xylem XYL Stock Holding History

Vectors Research Management’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-501
Closed -$43K – 533
2022
Q1 		$43K Sell
501
-1,502
-75% -$144K 0.01% 237
2021
Q4 		$240K Hold
2,003
– – 0.05% 154
2021
Q3 		$248K Hold
2,003
– – 0.06% 141
2021
Q2 		$240K Hold
2,003
– – 0.06% 142
2021
Q1 		$211K Hold
2,003
– – 0.06% 135
2020
Q4 		$204K Buy
+2,003
New +$188K 0.06% 129

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vectors Research Management's XYL Position: Q2 2022 in Review

Vectors Research Management sold out of Xylem (XYL) in Q2 2022, closing a stake of 501 shares — an estimated $43K sold.

Vectors Research Management first reported a position in XYL in Q4 2020 and held it in 6 quarters. The position peaked at $248K in Q3 2021. 724 funds tracked by Wall St. Rank hold XYL as of Q2 2022.

  • Vectors Research Management reported no remaining Xylem position as of Q2 2022 after selling out during the quarter.
  • Vectors Research Management sold 501 Xylem shares in Q2 2022, an estimated $43K.
  • Vectors Research Management first reported a position in Xylem in Q4 2020 and held it in 6 quarters.
  • Vectors Research Management's Xylem position peaked at $248K in Q3 2021.
  • 724 funds tracked by Wall St. Rank held Xylem as of Q2 2022.

Based on Vectors Research Management's 13F filing for Q2 2022, filed 12 Aug 2022.